Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis

INTRODUCTION: The safety profile of adalimumab was previously reported in 23,458 patients across multiple indications. Here we report the long-term safety of adalimumab in adults with plaque psoriasis (Ps), hidradenitis suppurativa (HS), rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Burmester, Gerd R., Gordon, Kenneth B., Rosenbaum, James T., Arikan, Dilek, Lau, Winnie L., Li, Peigang, Faccin, Freddy, Panaccione, Remo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979455/
https://www.ncbi.nlm.nih.gov/pubmed/31748904
http://dx.doi.org/10.1007/s12325-019-01145-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979455/
https://www.ncbi.nlm.nih.gov/pubmed/31748904
http://dx.doi.org/10.1007/s12325-019-01145-8

Ejemplares similares